Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CANB - Can B Corp


Previous close
0.0098
0   0%

Share volume: 60,100
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$0.01
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-36.99%
1 Month
-33.94%
3 Months
-33.13%
6 Months
-84.43%
1 Year
-91.93%
2 Year
-99.64%
Key data
Stock price
$0.01
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.01 - $0.23
52 WEEK CHANGE
-$0.91
MARKET CAP 
693.886 K
YIELD 
N/A
SHARES OUTSTANDING 
63.659 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$161,869
AVERAGE 30 VOLUME 
$89,669
Company detail
CEO: Marco Alfonsi
Region: US
Website: https://canbiola.com
Employees: 4
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

canbiola, inc. (otcqb: canb) is a developer, manufacturer and seller of a variety of cannabidiol (hemp) based products such as oils, creams, moisturizers, chews,, isolate, gel caps, and concentrates. canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the cbd and the medical cannabis industry. cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure cbd products are legal in all 50 states. hemp cbd is the non-psychoactive component (no thc) used for treatment of pain, inflammation, and wellness programs. for more information about canbiola, inc., please visit: https://canbiola.com. additionally, canbiola’s wholly owned subsidiary pure health products, based in lacey, wa, is its prime development laboratory and production facility. canbiola’s duramed division has recently rolled out a durable medical device via its doctor network to treat pati

Recent news